Clinical Studies
Breast Care
Cardiology
Colon Cancer
Dermatology
Diabetes
Gastrointestinal
HIV/AIDS
Mental Health
Neurology
Obesity/Weight Management
Women's Health
Other
Special Features
Advances/Research
| Principal Investigator: | Agustin Busta, M.D. | |
| Time frame of study: | July 2005 – May 2007 | |
| Time frame of participation: | 22 months | |
| Location of Study: | Fierman Hall 317E. 17TH St. 7th Floor New York, NY 10003 |
|
| Contact Name, Number & Email: | Clinical Research Coordinator |
Summary:
The Division of Endocrinology and Metabolism at the Beth Israel
Medical Center is participating in a research project to assess and compare
the efficacy of Lantus Apidra multiply daily injections versus premix
insulin treatment in patients with diabetes Mellitus type 1 and type 2.
This is a multi-center, randomized, cross-over study.
Criteria
for Participation:
- Type 1 or type 2 diabetes mellitus at least 6 months
- Ages 21-70 years of age
- Using insulin for 3 months
- Willing and able to perform self-monitoring of blood glucose (SMBG)
and continous glocose monitoring (CGMS)